Swiss National Bank grew its holdings in Atrion Co. (NASDAQ:ATRI) by 8.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,602 shares of the medical instruments supplier’s stock after buying an additional 200 shares during the quarter. Swiss National Bank owned approximately 0.14% of Atrion worth $1,641,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Teacher Retirement System of Texas purchased a new position in shares of Atrion in the 4th quarter valued at approximately $323,000. Bank of Montreal Can lifted its stake in shares of Atrion by 25.7% in the 4th quarter. Bank of Montreal Can now owns 597 shares of the medical instruments supplier’s stock valued at $376,000 after purchasing an additional 122 shares during the period. Advisor Group Inc. lifted its stake in shares of Atrion by 5,826.7% in the 3rd quarter. Advisor Group Inc. now owns 889 shares of the medical instruments supplier’s stock valued at $598,000 after purchasing an additional 874 shares during the period. SG Americas Securities LLC purchased a new position in shares of Atrion in the 4th quarter valued at approximately $900,000. Finally, Susquehanna International Group LLP lifted its stake in shares of Atrion by 187.6% in the 3rd quarter. Susquehanna International Group LLP now owns 1,369 shares of the medical instruments supplier’s stock valued at $920,000 after purchasing an additional 893 shares during the period. Institutional investors and hedge funds own 59.17% of the company’s stock.
Separately, BidaskClub cut Atrion from a “hold” rating to a “sell” rating in a research note on Tuesday, December 12th.
Atrion (NASDAQ:ATRI) last released its earnings results on Tuesday, February 27th. The medical instruments supplier reported $4.66 EPS for the quarter. The company had revenue of $34.02 million during the quarter. Atrion had a return on equity of 19.53% and a net margin of 24.96%.
The company also recently announced a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 15th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date is Wednesday, March 14th. Atrion’s payout ratio is presently 24.35%.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/13/atrion-co-atri-shares-bought-by-swiss-national-bank.html.
Atrion Company Profile
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Co. (NASDAQ:ATRI).
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.